Call Us With No Obligation
(877) 446-9001
24 Hours/ 7 days a week

Contact us to start your claim today

Fentanyl (Duragesic)MethadoneOxyContin (oxycodone)Vicodin (hydrocodone)Dilaudid (hydromophone)Other


Yes I agree to the Terms & Conditions

Archive for February, 2013

FDA panel votes to approve new restrictions on hydrocodone, oxycodone

Wednesday, February 13th, 2013

A Food and Drug Administration advisory panel has voted to recommend new restrictions on the opioid painkillers hydrocodone and oxycodone. The panel said that the new safety guidelines were needed because of the high number of painkiller overdoses and addictions among users of the two drugs. (more…)

European officials say J&J made payments to delay generic fentanyl patch release

Thursday, February 7th, 2013

Antitrust officials in Europe have accused two of the world’s largest drug companies—Novartis and Johnson & Johnson—of colluding in a payment scheme designed to delay a less-expensive version of the fentanyl pain patch. Fentanyl is an extremely powerful opioid painkiller that is usually prescribed to cancer patients or other individuals with chronic pain. (more…)